Abstract | OBJECTIVE: A prospective, randomized, double-blind, placebo-controlled, parallel-group multicentre study to evaluate the efficacy and safety of diclofenac 4% spray gel for the treatment of acute, uncomplicated ankle sprain. METHODS: Outpatients with acute, uncomplicated, one-sided ankle sprain were randomly assigned to receive diclofenac 4% spray gel or placebo (vehicle) three times daily for 14 ± 1 days. The main efficacy endpoint was the intra-individual response to treatment (≥ 50% decrease in swelling of the injured ankle after a treatment period of ≤ 10 days). RESULTS: The response rate was significantly higher in the diclofenac group (n = 118) than the placebo group (n = 114) (91.5% vs. 82.5%). After 3-4 days' treatment, diclofenac spray significantly reduced swelling, spontaneous pain, pain on active movement and tenderness compared with placebo. Diclofenac spray was well tolerated, with a low overall rate of adverse events. CONCLUSIONS:
|
Authors | Hans-Georg Predel, Bruno Giannetti, Bernd Seigfried, Roberto Novellini, Georg Menke |
Journal | The Journal of international medical research
(J Int Med Res)
Vol. 41
Issue 4
Pg. 1187-202
(Aug 2013)
ISSN: 1473-2300 [Electronic] England |
PMID | 23908551
(Publication Type: Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Anti-Inflammatory Agents, Non-Steroidal
- Gels
- Placebos
- Diclofenac
|
Topics |
- Acute Disease
- Administration, Topical
- Adult
- Ankle Injuries
(drug therapy, physiopathology)
- Anti-Inflammatory Agents, Non-Steroidal
(therapeutic use)
- Diclofenac
(therapeutic use)
- Double-Blind Method
- Female
- Gels
- Humans
- Male
- Outpatients
- Pain
(drug therapy, physiopathology)
- Pain Measurement
- Placebos
- Prospective Studies
- Sprains and Strains
(drug therapy, physiopathology)
- Treatment Outcome
|